ArticleFrontiers in oncology2020
CD19 and CD30 CAR T-Cell Immunotherapy for High-Risk Classical Hodgkin's Lymphoma.
YuanBo Xue et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticleFrontiers in oncology2020
YuanBo Xue et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.